Component with Tylan logo in blue

Component® with Tylan®

Component® with Tylan® cattle implants — protect and maximize your implant investment
Compudose logo

Compudose®

Elanco's long-acting cattle implants — maximize performance for extended grazing or feeding periods
encore logo

Encore®

Elanco's long-acting cattle implants — maximize performance for extended grazing or feeding periods
Micotil logo

Micotil® (Tilmicosin injection)

Micotil — Put the benefits of the flex dose to work in your operation
Optaflexx Logo

Optaflexx® (Ractopamine hydrochloride)

More Profit Potential
Pulmotil logo on pink

Pulmotil® (Tilmicosin)

14 days of sustained BRD control in the palm of your hands
Rumensin logo

Rumensin® (Monensin Feedyard and Pasture)

Rumensin® — Adding more profit to the bottom line
Standguard logo

StandGuard® Pour-On

StandGuard Pour-on—delivers quick-kill action
Tylan Logo

Tylan® Premix (Tylosin)

A proven, therapeutic cattle feed ingredient
Tylan Injection Logo

Tylan® Injection (Tylosin)

Tylan 200 Injection — a versatile, cost-effective cattle antibiotic

HeifermaX® (melengestrol acetate)

Manage Estrus, Improve Feedyard Performance

Pulmotil logo on pink
Pulmotil® (Tilmicosin)

14 days of sustained BRD control in the palm of your hands

Effective BRD control isn't just a chute-side protocol anymore

Pulmotil is an innovative bovine respiratory disease (BRD) treatment for groups of cattle in the early stages of a BRD outbreak. It provides 14 days of sustained in-feed therapy, a practice that reduces stress associated with cattle handling.

Pulmotil is ideal for cattle not requiring a metaphylaxis treatment on arrival and/or when labor resources are limited. Feeding Pulmotil means fewer pulls and less individual animal management.

Four-study registration summary — reduced pulls1:

Cattle were allocated to a negative control or Pulmotil treatment when 10% or more of the calves received at the study sites showed active signs of BRD. Day 0 represents when the cattle started treatment. Therapy stopped at the end of day 14.

  • Reduced BRD pulls (failures) by 35.6%
  • Fewer pulls starting at day four (Chart 1)
  • Reduced cumulative morbidity through day 28
  • No difference in daily feed intake was observed

Pulmotil Widget Image PNG

pulmotil-accumulated-daily-brd-related-morbidity

Implementing Pulmotil

To help ensure human food safety, the FDA established requirements for use of Pulmotil for the control of BRD. Be sure to work with your veterinarian to make sure the following requirements are met as you integrate Pulmotil into your BRD management program:

  • Contact your veterinarian for a Veterinary Feed Directive (VFD) and to develop a Pulmotil protocol for use once a 10% BRD diagnosis threshold has been reached in the group of cattle
  • Initiate the 14-day Pulmotil treatment within the first 45 days of the production period and only in groups of cattle that have not received an injectable macrolide antibiotic
  • Injectable macrolide antibiotics can be used once the Pulmotil treatment has ended
  • Pulmotil treatment can begin three days following the administration of a non-macrolide injectable BRD therapy
  • If the treatment must be initiated sooner, exclude calves treated with the injectable therapy from the group receiving Pulmotil

For Pulmotil: Feeds containing tilmicosin must be withdrawn 28 days prior to slaughter.

Important Safety Information

The label contains complete use information, including cautions and warnings. Always read, understand and follow the label and use directions. Avoid inhalation, oral exposure and direct contact with skin or eyes. VFD expiration date must not exceed 45 days from the time of issuance. VFDs shall not be refilled. Use only in cattle fed in confinement for slaughter. Cattle with severe clinical illness should be evaluated for individual treatment with an alternative non-macrolide therapy. Do not use in female dairy cattle 20 months of age or older or in veal calves. Safety has not been established in cattle intended for breeding. Do not allow horses or other equines access to feeds containing tilmicosin.

CAUTION: Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

For the control of Bovine Respiratory Disease (BRD) associated with Mannheimia haemolyticaPasteurella multocida and Histophilus somni in groups of beef and non-lactating dairy cattle, where active BRD has been diagnosed in at least 10% of the animals in the group: Feed continuously for a single, 14-day period at 568 to 757 g/ton of tilmicosin (100% DM basis) in a Type C medicated feed as the sole ration to provide 12.5 mg/kg of body weight/day.

Directions

Feed continuously for a single, 14-day period at 568 to 757 g/ton of tilmicosin (100% DM basis) in a Type C medicated feed as the sole ration to provide 12.5 mg/kg of body weight/day.

1 Pulmotil 90 Freedom of Information Summary (NADA 141-064).

Pulmotil is a trademark of Eli Lilly and Company or its affiliates.